Insulin aspart, recombinant Subcutaneous and Lotemax
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lotemax and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: loteprednol ophthalmic
Brand name: Alrex, Inveltys, Lotemax, Lotemax SM
Synonyms: Lotemax (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lotemax (Loteprednol Eye Drops 0.5% and 1%)
- Insulin aspart, recombinant Subcutaneous-Lotemax (Loteprednol Eye Gel)
- Insulin aspart, recombinant Subcutaneous-Lotemax (Loteprednol Eye Ointment)
- Insulin aspart, recombinant Subcutaneous-Lotemax Eye Gel
- Insulin aspart, recombinant Subcutaneous-Lotemax Eye Ointment
- Insulin aspart, recombinant Subcutaneous-Lotemax ophthalmic
- Lotemax-Insulin degludec
- Lotemax-Insulin Degludec (U-100) Prefilled Pens
- Lotemax-Insulin Degludec (U-100) Vials
- Lotemax-Insulin Degludec (U-200) Prefilled Pens
- Lotemax-Insulin degludec and liraglutide
- Lotemax-Insulin degludec and liraglutide Subcutaneous